FETALTONIN Trademark

Trademark Overview

On Monday, November 13, 2017, a trademark application was filed for FETALTONIN with the United States Patent and Trademark Office. The USPTO has given the FETALTONIN trademark a serial number of 87682216. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 12, 2021. The FETALTONIN trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical or medical purposes, namely, for adjusting circadian rhythms
fetaltonin

General Information

Serial Number87682216
Word MarkFETALTONIN
Filing DateMonday, November 13, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements

Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for adjusting circadian rhythms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMilwaukie, OR 97267
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMilwaukie, OR 97267

Trademark Events

Event DateEvent Description
Monday, July 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2021EXTENSION 5 GRANTED
Wednesday, December 2, 2020EXTENSION 5 FILED
Wednesday, December 2, 2020TEAS EXTENSION RECEIVED
Thursday, November 5, 2020ASSIGNED TO EXAMINER
Tuesday, June 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 6, 2020EXTENSION 4 GRANTED
Wednesday, June 3, 2020EXTENSION 4 FILED
Wednesday, June 3, 2020TEAS EXTENSION RECEIVED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 5, 2019EXTENSION 3 GRANTED
Tuesday, December 3, 2019EXTENSION 3 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Thursday, June 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2019EXTENSION 2 GRANTED
Friday, May 31, 2019EXTENSION 2 FILED
Wednesday, June 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 31, 2019TEAS EXTENSION RECEIVED
Wednesday, December 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 3, 2018EXTENSION 1 GRANTED
Monday, December 3, 2018EXTENSION 1 FILED
Monday, December 3, 2018TEAS EXTENSION RECEIVED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 26, 2018ASSIGNED TO EXAMINER
Friday, November 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 16, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

fetaltonin adjusting circadian rhythms namely purposes preparations pharmaceutical medical chemical